+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
ID07107477

Study Comparing Tailored Antibiotic and Steroid Treatment Based on Amniotic Fluid IL-6 Levels to Standard Care in Women With Preterm Premature Rupture of Membranes to Prolong Pregnancy and Improve Outcomes

Led by The Central and Eastern European Gynecologic Oncology Group · Updated on 2026-06-18

138

Participants Needed

3

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether using a lab test called interleukin-6 IL-6 from amniotic fluid can help guide antibiotic and steroid treatment to safely prolong pregnancy in people who experience preterm premature rupture of membranes pPROM. This condition causes the water to break too early before 37 weeks, increasing risks of infection and early birth. The study aims to see if tailoring treatment based on IL-6 can help pregnancies last more than 7 days after pPROM and improve health outcomes for both parent and baby. Participants will be randomly assigned to one of two groups. One group receives treatment tailored to IL-6 levels from weekly amniocentesis tests, where steroids and antibiotics are adjusted based on the lab results. The other group receives standard care with antibiotics and steroids given right after diagnosis. The study also includes neuroprotection treatment for imminent preterm birth before 32 weeks, with detailed antibiotic regimens and monitoring. Participants will undergo screening to confirm pPROM and eligibility, then receive hospital monitoring until delivery, including weekly amniocentesis if in the tailored group. After birth, follow-up lasts 6 months to track health outcomes for both parent and child. Researchers will measure how long the pregnancy lasts after membrane rupture, rates of infection, and short-term maternal and neonatal health outcomes to evaluate the treatment approaches.

CONDITIONS

Brief Title

TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden

Research Team

K

Katerina Mackova, MD, PhD, PhD

M

Martina Boricnova, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here